环苯唑啉琥珀酸酯[2-(2,2-二苯基环丙基)-2-咪唑啉琥珀酸脂]是一个新型的抗心律失常药,化学结构上与任何已知的抗心律失常药均不同。根据Vaughan-Williams 的分类,本品属第一类抗心律失常药,但也具有第三和第四类的一些性质。第一类抗心律失常药如吡二丙胺、奎尼丁、普鲁卡因酰胺和溴苄胺托西酸盐是通过与M 胆碱受体作用而发挥药效的,它们是M 受体拮抗剂。这一性质是治疗中常见副作用的原因。本文通过体外和体内 Cyclobenzazoline succinate [2- (2,2-diphenylcyclopropyl) -2-imidazoline succinate] is a novel antiarrhythmic drug that is chemically structurally related to any known anti-arrhythmic Disorders are different. According to the Vaughan-Williams classification, this product is the first anti-arrhythmic drug, but also has some properties of the third and fourth categories. The first class of anti-arrhythmic drugs such as pyrilamine, quinidine, procainamide and bromobenzotocate exert their effects by acting on the M choline receptor, which are M receptor antagonists Agent. This property is the reason for the common side effects of treatment. This article through in vitro and in vivo